Evidence map›Paper›PMID 42185972›Full record

Observational studyBMC cardiovascular disorders2026

Admission and 24-hour heart rates and in-hospital outcomes in STEMI undergoing primary PCI.

Yuke Cui, Zhihong Xu, Xuezheng Qu, Tianqi Zhu, Shuo Feng, Hui Han, Ruiyan Zhang, Xiaoxiang Yan, Weiwei Quan

Abstract readObservational Study
In one paragraph

Observational study in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuke Cui *Department of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.
Zhihong Xu *Department of Geriatric Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, China.
Xuezheng QuDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.
Tianqi ZhuDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.
Shuo FengDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.
Hui HanDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.
Ruiyan ZhangDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.
Xiaoxiang YanDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China. cardexyanxx@hotmail.com.
Weiwei QuanDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China. springqww@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart rate (HR) plays a central role in cardiac physiology and has been closely associated with major cardiovascular (CV) outcomes, including heart failure, ischemic heart disease, and cardiovascular mortality. However, whether HR can serve as an early predictor of in-hospital outcomes among patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) remains unclear. This study aimed to evaluate the associations between heart rate at first medical contact (FHR), at hospital admission (AHR), and at 24 h post-admission (24 h) with adverse in-hospital outcomes.

methodsThis retrospective single-center observational study included 309 consecutive patients with STEMI who underwent PPCI between September 2018 and December 2020 at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Associations between the three HR measurements and in-hospital adverse cardiovascular events were analyzed using binary logistic regression models. Both crude models and models adjusted for conventional risk factors, biomarkers, and treatment variables were assessed.

resultsBoth AHR and 24 h were positively associated with in-hospital CV events, predominantly acute heart failure (P < 0.05), which were predominantly driven by acute heart failure. After adjusting for potential confounders, the odds of having in-hospital CV events were significantly enhanced by an increase in AHR and 24 h (odds ratio [OR]: 1.033, 95% confidence intervals [CI]: 1.008-1.060; OR: 1.037, 95% CI: 1.003-1.071, respectively). Additionally, every 5 bpm increase in AHR and 24 h was associated with an 18.6% and a 19.8% increased risk of in-hospital CV events, respectively. In contrast, FHR showed limited predictive value for such events.

conclusionAmong STEMI patients undergoing PPCI, elevated admission and 24-hour heart rates are significantly associated with adverse in-hospital cardiovascular outcomes. Admission heart rate, in particular, may serve as a simple and reliable prognostic indicator for identifying patients at increased short-term risk.

Indexed as

Heart RatePatient AdmissionPercutaneous Coronary InterventionST Elevation Myocardial InfarctionAgedChinaFemaleHospital MortalityHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsAdverse in-hospital CV eventsHeart ratePrimary percutaneous coronary intervention (PPCI)ST-segment elevation acute myocardial infarction (STEMI)

Identifiers

PMID42185972
PMCPMC13383127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.